3-164660905-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000701346.1(ENSG00000289884):​n.608-26723C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.527 in 151,888 control chromosomes in the GnomAD database, including 21,880 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 21880 hom., cov: 32)

Consequence

ENSG00000289884
ENST00000701346.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.46

Publications

3 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000701346.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.684 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000701346.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000289884
ENST00000701346.1
n.608-26723C>G
intron
N/A
ENSG00000289884
ENST00000702159.2
n.496-26723C>G
intron
N/A
ENSG00000289884
ENST00000721983.1
n.278-26723C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.527
AC:
79923
AN:
151772
Hom.:
21850
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.691
Gnomad AMI
AF:
0.411
Gnomad AMR
AF:
0.478
Gnomad ASJ
AF:
0.365
Gnomad EAS
AF:
0.495
Gnomad SAS
AF:
0.497
Gnomad FIN
AF:
0.521
Gnomad MID
AF:
0.440
Gnomad NFE
AF:
0.454
Gnomad OTH
AF:
0.499
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.527
AC:
80001
AN:
151888
Hom.:
21880
Cov.:
32
AF XY:
0.527
AC XY:
39098
AN XY:
74212
show subpopulations
African (AFR)
AF:
0.691
AC:
28649
AN:
41450
American (AMR)
AF:
0.478
AC:
7284
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.365
AC:
1267
AN:
3472
East Asian (EAS)
AF:
0.495
AC:
2542
AN:
5138
South Asian (SAS)
AF:
0.495
AC:
2382
AN:
4808
European-Finnish (FIN)
AF:
0.521
AC:
5484
AN:
10534
Middle Eastern (MID)
AF:
0.456
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
0.454
AC:
30833
AN:
67944
Other (OTH)
AF:
0.498
AC:
1052
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1870
3740
5609
7479
9349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
706
1412
2118
2824
3530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.356
Hom.:
952
Bravo
AF:
0.532

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.20
DANN
Benign
0.28
PhyloP100
-1.5

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2643191;
hg19: chr3-164378693;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.